You can buy or sell IPCI and other stocks, options, ETFs, and crypto commission-free!
Intellipharmaceutics International Inc. Common Stock, also called Intellipharmaceutics, is a pharmaceutical company, which engages in the research, development, and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Read More Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of existing and new pharmaceuticals in the areas of neurology, cardiovascular, gastrointestinal tract, diabetes and pain. The company was founded by Isa Odidi and Amina Odidi in 1998 and is headquartered in Toronto, Canada.
52 Week High
52 Week Low
Investors That Purchased Intellipharmaceutics International Inc. (“IPCI”) Securities Listed on the Toronto Stock Exchange May Have an Opportunity to Recover Their Financial Losses
TORONTO--(BUSINESS WIRE)--Morganti & Co., P.C., a cross border shareholder’s rights law firm, has commenced a shareholder class action lawsuit against Intellipharmaceutics International Inc.
Expected Apr 15, After Hours